- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Under the auspices of the Xiangshan Science Conferences (XSSC), a symposium was held from 18 to 20 December in Beijing to deal with the key S&T issues in molecular imaging and related application.
The meeting was co-chaired by TIAN Jie from the CAS Institute of Automation, TANG Xiaowei from Zhejiang University, WANG Weiqi from Fudan University, BAI Jing from Tsinghua University, and BAO Shanglian from Peking University.
Molecular imaging is a newly emerging field of study that involves many academic disciplines, such as informatics, molecular biology, chemistry, physics, radiological medicine, nuclear medicine and clinics. The technology is able to obtain three-dimensional images about the physiological and pathological changes of an organism at the molecular level in an in-vivo, real-time, dynamic and no-invasive way. In addition, it is also expected to offer effective approaches for data acquisition, analysis and processing in research into specific functions of genomes, growth of organisms, disease development and drug efficacy assessment.
At present, molecular imaging has become an interdisciplinary "hot spot", among which radionuclide-based molecular imaging has been used for the human body and found primary applications in clinics. However, there still exist many science fundamentals to be solved. As a new research focus for the whole area, optical molecular imaging labeled with fluorescence in particular, is still in its fledgling development stage and needs strengthened efforts.
Molecular imaging will eventually provide new and revolutionary methods for life sciences and clinical medicine, according to experts. As the in-vivo studies of activities of genes, bio-macromolecules, and cells are a major research target for the 21st century life sciences, it will be beneficial for developing brand-new methods for the alert, diagnosis, and treatment of diseases, and is vital for upgrading people's health and living standards.
The participants of the XSSC symposium focused their discussions on such topics as studies of optical molecular imaging and application; radionuclide-based molecular imaging studies and application; multimodal molecular imaging and application; key issues in molecular probes; molecular diagnosis and its clinical application; important roles of molecular imaging in the development of anti-cancer drugs.
At the meeting, Prof. TIAN Jie and LIANG Wei from the CAS Institute of Automation delivered keynote roundup reports on multimodal diagnosis and its clinical application, and status and demands for the application of molecular imaging in life sciences, respectively.
About Chinese Academy of Sciences
CAS strives to build itself into a scientific research base at advanced international level, a base for fostering and bringing up advanced S&T talents, and a base for promoting the development of China's high and new technology industries. By 2010, CAS will have about 80 national institutes noted for their powerful capacities in S&T innovation and sustainable development or with distinctive features; thirty of them will become internationally acknowledged, high-level research institutions, and three to five will be world class.
For more information, please click here
Chinese Academy of Sciences
Add: 52 Sanlihe Rd., Beijing China
Tel: 86 10 68597289
Fax: 86 10 68512458
Bulletin of Chinese Academy of Sciences
CAS Institute of Policy & Management,
P.O.Box 8712, Beijing 100080, China.
Copyright © Chinese Academy of SciencesIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
ORNL reports method that takes quantum sensing to new level April 23rd, 2015
Richards-Kortum elected to American Academy of Arts and Sciences: April 22nd, 2015
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015